Baker Avenue Asset Management, LP Moderna, Inc. Transaction History

Baker Avenue Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $19,667 - $25,828	-204 Reduced 42.59%	275 $28,000
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $23,344 - $31,624	197 Added 69.86%	479 $58,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $406 - $591	-3 Reduced 1.05%	282 $43,000
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $33,738 - $59,861	285 New	285 $51,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.